The success of Axiron and the animal health products is entirely up to Eli Lilly and out of Acrux's hands now. There's still a new European partner for Ellavie to be found, but Evamist/Ellavie is largely a finished product too.
So I want to know what Acrux is doing to move the rest of its pipeline along, especially since they have the funds to do that properly now. What's happening with Luramist? Have the NSAIDs and nicotine projects gone anywhere? What new applications of the technology can they find?
I hope they're not just sitting around waiting for a takeover!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $6.116M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.5¢ | $1.574K | 104.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 609316 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 388346 | 2 |
View Market Depth
| Last trade - 11.39am 26/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |